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Osrin (UCL), Preeti Patel (King’s College London), Peter Piot (LSHTM), Martin Prince (Kings), 
Jim Smith (Wellcome Trust), Robert J Wilkinson (Francis Crick Institute), and Richard Horton1 
 
Innovation is essential to address the complex problems in global health today—widening 
inequity, changing patterns of disease burden, the impacts of conflict, migration, natural 
disasters, and climate change. Many approaches to these challenges are well recognised: 
crossdisciplinary research, evidence-based practice, and a consideration of the behavioural, 
cultural, social, political, and economic determinants of health.1 Solutions, however, require 
innovative approaches to ensure the full participation of low-income and middle-income 
countries (LMICs) in shaping the global health agenda. This is not currently the case: global 
health’s major donors set priorities as part of internal processes that respond only partly to 
the priorities of LMIC citizens and governments.2 Efforts by global health actors to challenge 
paternalism in the North–South aid relationship are increasingly threatened by the rise of 
populism in high-income countries (HICs), divisive political movements such as Brexit, and 
rising inequalities within and between countries.3 Overcoming these political challenges will 
require innovation and activism by the global health community. 
As one of the largest bilateral funders, with an annual official development assistance 
(ODA) budget for health in excess of £1 billion,4 the UK has a role in facilitating the active 
participation of LMICs in developing the global health agenda. With this in mind, we examine 
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the example of UK research and development institutions, and identify some innovative 
approaches. 
First, there is a need to increase the involvement of LMIC partners in identifying what 
works to address complex global health problems. Experiences of HIV/AIDS in Africa during 
the 1990s, including the failure of large-scale interventions that relied on western 
understandings of the epidemic while prevalence skyrocketed, have shown the vital 
importance of understanding local context.5 Examples of initiatives that put LMIC practices 
and experiences at the heart of intervention design include: a series of local action and 
community participation interventions to improve maternal and newborn survival outcomes 
in Bangladesh, India, Malawi, and Nepal;6 the use of urban women’s and children’s 
community resource centres to respond to the needs of India’s National Health Mission;7 and 
responses to gender-based violence based on local need and existing programmes.8 
Second, understanding local context should inform the use of new technologies as 
benchmarks for innovation. Indiscriminate use of technology can reinforce existing hierarchies 
by emphasising LMICs as the problem and HICs as the source of solutions.9 Equally, technology 
designed with local needs and resources in mind can increase the impact of effective 
interventions. One example of this approach is Peek Vision, a social impact organisation that 
uses smartphone technology and incentive-based financing to increase access to eye care in 
Botswana, India, and Kenya.10 In Kenya, a locally adapted smartphone app was used by 
teachers to identify school children with visual impairment; 21 000 children were screened by 
25 teachers and 900 children identified with visual impairment in only 9 days. Technology 
alone cannot solve complex problems, but locally adapted technologies can greatly amplify 
existing efforts. 
Third, innovation is required to overcome the misalignment between research funding 
that originates in HICs and the needs and priorities of LMICs. For example, an assessment of 
funding by disease shows that although acute respiratory infections account for 25% of the 
infectious disease burden in LMICs, they receive only 3% of direct aid.11 Inequality in the 
funding relationship between HICs and LMICs is compounded by insufficient funding from 
LMIC governments—a vicious circle in which human resource and skills shortfalls compromise 
governments’ ability to prioritise global health issues and effective actions. 
UK funders are trying to address these problems. Examples include: the £1·5 billion 
Global Challenges Research Fund for the development needs of ODA-recipient countries; the 
Wellcome Developing Excellence in Leadership, Training and Science Initiative (DELTAS) for 
research and training programmes led by African scholars; and the £735 million Newton Fund, 
which includes partner countries in decision making and financial contributions. These 
innovative models need to be studied. Major funding schemes from resource-rich settings 
should be designed to encourage and leverage local LMIC co-funding for better ownership 
and sustainability of research programmes. 
UK innovation in global health arises from an awareness that the full participation of 
LMICs is essential for solving complex global health problems. Examples of how this can be 
done are emerging from UK research institutions and funding bodies, including shared 
funding structures, co-production of interventions and evidence, and locally adapted 
technologies. However, innovative approaches will require a multiplication of such efforts 
until LMICs that have the highest burden of disease are actually driving the agenda. In the 
current political climate, this is a radical proposition that requires us all to become global 
health activists. 
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